Press Releases
Quaker Houghton Announces Third Quarter 2022 Results
- Net sales of
$492.2 million increased 10% compared to Q3'21 driven by higher selling prices - Reported net income of
$25.9 million and earnings per diluted share of$1.44 - Non-GAAP net income of
$31.2 million and non-GAAP earnings per diluted share of$1.74 - Delivered
$70.3 million of adjusted EBITDA, a 6% increase compared to$66.2 million in Q3'21 - Sequential margin improvement as we executed on our value-based pricing initiatives
Three Months Ended |
Nine Months Ended |
|||||||||
($ in millions, except per share data) |
2022 |
2021 |
2022 |
2021 |
||||||
Net sales |
$ 492.2 |
$ 449.1 |
$ 1,458.8 |
$ 1,314.1 |
||||||
Net income attributable to |
25.9 |
31.1 |
60.0 |
103.2 |
||||||
Earnings per diluted share attributable to |
1.44 |
1.73 |
3.35 |
5.76 |
||||||
Non-GAAP net income * |
31.2 |
29.4 |
80.3 |
99.8 |
||||||
Non-GAAP earnings per diluted share * |
1.74 |
1.63 |
4.48 |
5.56 |
||||||
Adjusted EBITDA * |
70.3 |
66.2 |
189.2 |
213.4 |
||||||
* |
Refer to the Non-GAAP Measures and Reconciliations section below for additional information |
Third Quarter 2022 Consolidated Results
Third quarter 2022 net sales were
The Company generated net income in the third quarter of 2022 of
Looking ahead, we expect the current uneven demand environment and seasonal demand trends to weigh on our end markets in the fourth quarter. We expect to deliver sequential margin expansion in the fourth quarter of 2022 as we continue to work to return to pre-pandemic margin levels. We remain focused on improving our profitability through additional pricing and cost controls and simplifying our operating model to align with the macroeconomic environment, while continuing to prioritize new business wins.
The resilience of our business is evident, and our differentiated customer intimate model is core to our strategy. Importantly, we will continue to invest in our strategic growth initiatives and advance our global efficiency measures to maximize the benefit of our expertise and scale and better position the Company to drive long-term profitable growth."
Third Quarter 2022 Segment Results
The Company's third quarter 2022 operating performance of each of its four reportable operating segments: (i)
Three Months Ended |
Nine Months Ended |
||||||||
|
2022 |
2021 |
2022 |
2021 |
|||||
|
$ 186.5 |
$ 150.8 |
$ 513.4 |
$ 425.3 |
|||||
EMEA |
113.4 |
122.2 |
362.1 |
365.5 |
|||||
|
91.2 |
98.7 |
295.3 |
286.9 |
|||||
Global Specialty Businesses |
101.1 |
77.4 |
288.0 |
236.4 |
|||||
Segment operating earnings* |
|||||||
|
$ 45.0 |
$ 31.3 |
$ 108.0 |
$ 97.2 |
|||
EMEA |
9.9 |
20.2 |
39.9 |
68.8 |
|||
|
23.3 |
23.3 |
67.5 |
74.0 |
|||
Global Specialty Businesses |
30.7 |
20.7 |
83.6 |
69.0 |
* |
Refer to the Segment Measures and Reconciliations section below for additional information |
The
All four segments benefitted from increases in selling price and product mix compared to the second quarter of 2022, as we continued to work with customers to implement our value-based pricing initiatives. Organic sales volumes increased compared to the second quarter of 2022 in the
Cash Flow and Liquidity Highlights
The Company had a net operating cash outflow of
As of
Non-GAAP Measures and Reconciliations
The information included in this press release includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income and non-GAAP earnings per diluted share. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are indicative of future operating performance of the Company, and facilitate a comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not indicative of future operating performance or not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.
The Company presents EBITDA which is calculated as net income attributable to the Company before depreciation and amortization, interest expense, net, and taxes on income before equity in net (loss) income of associated companies. The Company also presents adjusted EBITDA which is calculated as EBITDA plus or minus certain items that are not indicative of future operating performance or not considered core to the Company's operations. In addition, the Company presents non-GAAP operating income which is calculated as operating income plus or minus certain items that are not indicative of future operating performance or not considered core to the Company's operations. Adjusted EBITDA margin and non-GAAP operating margin are calculated as the percentage of adjusted EBITDA and non-GAAP operating income to consolidated net sales, respectively. The Company believes these non-GAAP measures provide transparent and useful information and are widely used by investors, analysts, and peers in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
Additionally, the Company presents non-GAAP net income and non-GAAP earnings per diluted share as additional performance measures. Non-GAAP net income is calculated as adjusted EBITDA, defined above, less depreciation and amortization, interest expense, net, and taxes on income before equity in net (loss) income of associated companies, in each case adjusted, as applicable, for any depreciation, amortization, interest or tax impacts resulting from the non-core items identified in the reconciliation of net income attributable to the Company to adjusted EBITDA. Non-GAAP earnings per diluted share is calculated as non-GAAP net income per diluted share as accounted for under the "two-class share method." The Company believes that non-GAAP net income and non-GAAP earnings per diluted share provide transparent and useful information and are widely used by investors, analysts, and peers in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
As it relates to 2022 projections for the Company as well as other forward-looking information described further above, the Company has not provided guidance for comparable GAAP measures or a quantitative reconciliation of forward-looking non-GAAP financial measures to the most directly comparable
The Company's reference to trailing twelve months adjusted EBITDA within this press release refers to the twelve month period ended
Certain of the prior period non-GAAP financial measures presented in the following tables have been adjusted to conform with current period presentation. The following tables reconcile the Company's non-GAAP financial measures (unaudited) to their most directly comparable GAAP (unaudited) financial measures (dollars in thousands unless otherwise noted, except per share amounts):
Non-GAAP Operating Income and Margin Reconciliations |
||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
Operating income |
$ 44,609 |
$ 36,010 |
$ 105,915 |
$ 119,720 |
||||||||||||
Combination, restructuring and other |
717 |
5,083 |
7,421 |
20,371 |
||||||||||||
acquisition-related expenses (a) |
||||||||||||||||
Strategic planning and transformation expenses |
4,545 |
— |
10,745 |
— |
||||||||||||
Executive transition costs |
913 |
285 |
2,097 |
1,097 |
||||||||||||
|
88 |
— |
2,183 |
— |
||||||||||||
Facility remediation costs, net |
— |
1,490 |
— |
1,490 |
||||||||||||
Other charges |
70 |
320 |
546 |
613 |
||||||||||||
Non-GAAP operating income |
$ 50,942 |
$ 43,188 |
$ 128,907 |
$ 143,291 |
||||||||||||
Non-GAAP operating margin (%) |
10.3 % |
9.6 % |
8.8 % |
10.9 % |
||||||||||||
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin |
||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
2022 |
2021 |
2022 |
2021 |
|||||||||||||
Net income attributable to |
$ 25,867 |
$ 31,058 |
$ 60,026 |
$ 103,243 |
||||||||||||
Depreciation and amortization (a)(b) |
19,908 |
21,542 |
61,491 |
66,334 |
||||||||||||
Interest expense, net |
8,389 |
5,637 |
20,228 |
16,725 |
||||||||||||
Taxes on income before equity in net (loss) income |
10,185 |
795 |
14,425 |
26,702 |
||||||||||||
of associated companies (c) |
||||||||||||||||
EBITDA |
$ 64,349 |
$ 59,032 |
$ 156,170 |
$ 213,004 |
||||||||||||
Equity loss (income) in a captive insurance company |
174 |
(108) |
2,199 |
(4,071) |
||||||||||||
Combination, restructuring and other |
717 |
4,906 |
9,817 |
14,265 |
||||||||||||
acquisition-related expenses (a) |
||||||||||||||||
Strategic planning and transformation expenses |
4,545 |
— |
10,745 |
— |
||||||||||||
Executive transition costs |
913 |
285 |
2,097 |
1,097 |
||||||||||||
|
88 |
— |
2,183 |
— |
||||||||||||
Facility remediation (recovery) costs, net |
(1,104) |
2,019 |
(1,104) |
2,019 |
||||||||||||
Brazilian non-income tax credits |
— |
— |
— |
(13,293) |
||||||||||||
Loss on extinguishment of debt |
— |
— |
6,763 |
— |
||||||||||||
Other charges |
609 |
35 |
356 |
353 |
||||||||||||
Adjusted EBITDA |
$ 70,291 |
$ 66,169 |
$ 189,226 |
$ 213,374 |
||||||||||||
Adjusted EBITDA margin (%) |
14.3 % |
14.7 % |
13.0 % |
16.2 % |
||||||||||||
Adjusted EBITDA |
$ 70,291 |
$ 66,169 |
$ 189,226 |
$ 213,374 |
||||||||||||
Less: Depreciation and amortization - adjusted (a)(b) |
19,908 |
21,365 |
61,491 |
65,616 |
||||||||||||
Less: Interest expense, net |
8,389 |
5,637 |
20,228 |
16,725 |
||||||||||||
Less: Taxes on income before equity in net |
10,821 |
9,765 |
27,189 |
31,277 |
||||||||||||
income of associated companies – adjusted (c) |
||||||||||||||||
Non-GAAP net income |
$ 31,173 |
$ 29,402 |
$ 80,318 |
$ 99,756 |
||||||||||||
Non-GAAP Earnings per Diluted Share Reconciliations |
|||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||
2022 |
2021 |
2022 |
2021 |
||||||||
GAAP earnings per diluted share attributable to |
$ 1.44 |
$ 1.73 |
$ 3.35 |
$ 5.76 |
|||||||
Equity loss (income) in a captive insurance company per diluted share |
0.01 |
(0.01) |
0.12 |
(0.23) |
|||||||
Combination, restructuring and other acquisition-related expenses per diluted share (a) |
0.04 |
0.22 |
0.45 |
0.64 |
|||||||
Strategic planning and transformation expenses per diluted share |
0.19 |
— |
0.46 |
— |
|||||||
Executive transition costs per diluted share |
0.04 |
0.01 |
0.09 |
0.05 |
|||||||
|
0.01 |
— |
0.11 |
— |
|||||||
Facility remediation (recovery) costs, net per diluted share |
(0.05) |
0.09 |
(0.05) |
0.09 |
|||||||
Brazilian non-income tax credits per diluted share |
— |
(0.04) |
— |
(0.48) |
|||||||
Loss on extinguishment of debt per diluted share |
— |
— |
0.29 |
— |
|||||||
Other charges per diluted share |
0.04 |
— |
0.03 |
0.02 |
|||||||
Impact of certain discrete tax items per diluted share |
0.02 |
(0.37) |
(0.37) |
(0.29) |
|||||||
Non-GAAP earnings per diluted share |
$ 1.74 |
$ 1.63 |
$ 4.48 |
$ 5.56 |
|||||||
(a) |
The Company recorded |
(b) |
Depreciation and amortization for the three and nine months ended |
(c) |
Taxes on income before equity in net (loss) income of associated companies – adjusted includes the Company's tax expense adjusted for the impact of any current and deferred income tax expense (benefit), as applicable, of the reconciling items presented in the reconciliation of Net income attributable to |
Segment Measures and Reconciliations
The Company's operating segments, which are consistent with its reportable segments, reflect the structure of the Company's internal organization, the method by which the Company's resources are allocated and the manner by which the chief operating decision maker assesses the Company's performance. The Company has four reportable segments: (i)
The following tables reconcile the Company's reportable operating segments performance to that of the Company (dollars in thousands):
Three Months Ended |
Nine Months Ended |
||||||||
|
2022 |
2021 |
2022 |
2021 |
|||||
|
$ 186,546 |
$ 150,799 |
$ 513,438 |
$ 425,343 |
|||||
EMEA |
113,367 |
122,241 |
362,107 |
365,491 |
|||||
|
91,211 |
98,659 |
295,273 |
286,924 |
|||||
Global Specialty Businesses |
101,094 |
77,373 |
287,959 |
236,359 |
|||||
Total net sales |
$ 492,218 |
$ 449,072 |
$ 1,458,777 |
$ 1,314,117 |
|||||
Segment operating earnings |
|||||||
|
$ 44,986 |
$ 31,273 |
$ 107,991 |
$ 97,155 |
|||
EMEA |
9,883 |
20,153 |
39,932 |
68,802 |
|||
|
23,336 |
23,285 |
67,469 |
73,990 |
|||
Global Specialty Businesses |
30,746 |
20,663 |
83,622 |
69,041 |
|||
Total segment operating earnings |
$ 108,951 |
$ 95,374 |
$ 299,014 |
$ 308,988 |
|||
Combination, integration and other |
(2,107) |
(5,786) |
(7,992) |
(18,259) |
|||
Restructuring and related charges (credits), net |
1,423 |
880 |
604 |
(593) |
|||
Fair value step up of acquired |
— |
— |
— |
(801) |
|||
Non-operating and administrative |
(47,852) |
(38,691) |
(139,894) |
(122,760) |
|||
Depreciation of corporate assets |
(15,806) |
(15,767) |
(45,817) |
(46,855) |
|||
Operating income |
44,609 |
36,010 |
105,915 |
119,720 |
|||
Other income (expense), net |
85 |
647 |
(10,520) |
19,344 |
|||
Interest expense, net |
(8,389) |
(5,637) |
(20,228) |
(16,725) |
|||
Income before taxes and equity |
$ 36,305 |
$ 31,020 |
$ 75,167 |
$ 122,339 |
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts. We have based these forward-looking statements, including statements regarding the potential effects of the COVID-19 pandemic, the
Conference Call
As previously announced, the Company's investor conference call to discuss its third quarter 2022 performance is scheduled for
About
|
|||||||
Condensed Consolidated Statements of Income |
|||||||
(Dollars in thousands, except per share data) |
|||||||
(Unaudited) |
|||||||
Three Months Ended |
Nine Months Ended |
||||||
2022 |
2021 |
2022 |
2021 |
||||
Net sales |
$ 492,218 |
$ 449,072 |
|
|
|||
Cost of goods sold |
331,469 |
303,941 |
1,002,393 |
858,341 |
|||
Gross profit |
160,749 |
145,131 |
456,384 |
455,776 |
|||
% |
32.7 % |
32.3 % |
31.3 % |
34.7 % |
|||
Selling, general and administrative expenses |
115,456 |
104,215 |
343,081 |
317,204 |
|||
Restructuring and related (credits) charges, net |
(1,423) |
(880) |
(604) |
593 |
|||
Combination, integration and other acquisition-related expenses |
2,107 |
5,786 |
7,992 |
18,259 |
|||
Operating income |
44,609 |
36,010 |
105,915 |
119,720 |
|||
% |
9.1 % |
8.0 % |
7.3 % |
9.1 % |
|||
Other (expense) income, net |
85 |
647 |
(10,520) |
19,344 |
|||
Interest expense, net |
(8,389) |
(5,637) |
(20,228) |
(16,725) |
|||
Income before taxes and equity in net (loss) income of associated companies |
36,305 |
31,020 |
75,167 |
122,339 |
|||
Taxes on income before equity in net (loss) income of associated companies |
10,185 |
795 |
14,425 |
26,702 |
|||
Income before equity in net (loss) income of associated companies |
26,120 |
30,225 |
60,742 |
95,637 |
|||
Equity in net (loss) income of associated companies |
(212) |
848 |
(642) |
7,668 |
|||
Net income |
25,908 |
31,073 |
60,100 |
103,305 |
|||
Less: Net income attributable to noncontrolling interest |
41 |
15 |
74 |
62 |
|||
Net income attributable to |
$ 25,867 |
$ 31,058 |
$ 60,026 |
$ 103,243 |
|||
% |
5.3 % |
6.9 % |
4.1 % |
7.9 % |
|||
Share and per share data: |
|||||||
Basic weighted average common shares outstanding |
17,847,305 |
17,812,216 |
17,835,976 |
17,800,082 |
|||
Diluted weighted average common shares outstanding |
17,859,871 |
17,870,392 |
17,851,411 |
17,860,068 |
|||
Net income attributable to |
$ 1.44 |
$ 1.74 |
$ 3.35 |
$ 5.78 |
|||
Net income attributable to |
$ 1.44 |
$ 1.73 |
$ 3.35 |
$ 5.76 |
|
|||
Condensed Consolidated Balance Sheets |
|||
(Dollars in thousands, except par value) |
|||
(Unaudited) |
|||
|
|
||
2022 |
2021 |
||
ASSETS |
|||
Current assets |
|||
Cash and cash equivalents |
$ 138,891 |
$ 165,176 |
|
Accounts receivable, net |
461,912 |
430,676 |
|
Inventories, net |
317,140 |
264,531 |
|
Prepaid expenses and other current assets |
66,760 |
59,871 |
|
Total current assets |
984,703 |
920,254 |
|
Property, plant and equipment, net |
188,374 |
197,520 |
|
Right of use lease assets |
37,005 |
36,635 |
|
Goodwill |
591,032 |
631,194 |
|
Other intangible assets, net |
915,956 |
1,027,782 |
|
Investments in associated companies |
76,748 |
95,278 |
|
Deferred tax assets |
10,519 |
16,138 |
|
Other non-current assets |
27,163 |
30,959 |
|
Total assets |
$ 2,831,500 |
$ 2,955,760 |
|
LIABILITIES AND EQUITY |
|||
Current liabilities |
|||
Short-term borrowings and current portion of long-term debt |
$ 20,471 |
$ 56,935 |
|
Accounts and other payables |
217,143 |
234,083 |
|
Accrued compensation |
32,993 |
38,197 |
|
Accrued restructuring |
1,798 |
4,087 |
|
Other accrued liabilities |
93,326 |
97,165 |
|
Total current liabilities |
365,731 |
430,467 |
|
Long-term debt |
931,491 |
836,412 |
|
Long-term lease liabilities |
25,697 |
26,335 |
|
Deferred tax liabilities |
151,208 |
179,025 |
|
Other non-current liabilities |
77,743 |
95,599 |
|
Total liabilities |
1,551,870 |
1,567,838 |
|
Equity |
|||
Common stock, |
17,931 |
17,897 |
|
Capital in excess of par value |
925,037 |
917,053 |
|
Retained earnings |
553,685 |
516,334 |
|
Accumulated other comprehensive loss |
(217,655) |
(63,990) |
|
Total Quaker shareholders' equity |
1,278,998 |
1,387,294 |
|
Noncontrolling interest |
632 |
628 |
|
Total equity |
1,279,630 |
1,387,922 |
|
Total liabilities and equity |
$ 2,831,500 |
$ 2,955,760 |
|
|||
Condensed Consolidated Statements of Cash Flows |
|||
(Dollars in thousands) |
|||
(Unaudited) |
|||
. |
Nine Months Ended |
||
2022 |
2021 |
||
Cash flows from operating activities |
|||
Net income |
$ 60,100 |
|
|
Adjustments to reconcile net income to net cash used in operating activities: |
|||
Amortization of debt issuance costs |
2,589 |
3,562 |
|
Depreciation and amortization |
60,692 |
65,440 |
|
Equity in undistributed earnings of associated companies, net of dividends |
3,612 |
(7,563) |
|
Acquisition-related fair value adjustments related to inventory |
- |
801 |
|
Deferred compensation, deferred taxes and other, net |
(8,811) |
(21,865) |
|
Share-based compensation |
8,635 |
8,441 |
|
Loss on extinguishment of debt |
5,246 |
- |
|
Gain on disposal of property, plant, equipment and other assets |
(33) |
(4,819) |
|
Combination and other acquisition-related expenses, net of payments |
(4,265) |
(1,705) |
|
Restructuring and related (credits) charges, net |
(604) |
593 |
|
Pension and other postretirement benefits |
(6,556) |
(5,638) |
|
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions: |
|||
Accounts receivable |
(65,256) |
(68,664) |
|
Inventories |
(72,386) |
(72,962) |
|
Prepaid expenses and other current assets |
(11,081) |
(24,512) |
|
Change in restructuring liabilities |
(1,234) |
(4,557) |
|
Accounts payable and accrued liabilities |
3,059 |
32,652 |
|
Net cash (used in) provided by operating activities |
(26,293) |
2,509 |
|
Cash flows from investing activities |
|||
Investments in property, plant and equipment |
(20,230) |
(12,823) |
|
Payments related to acquisitions, net of cash acquired |
(9,421) |
(31,975) |
|
Proceeds from disposition of assets |
65 |
14,744 |
|
Net cash used in investing activities |
(29,586) |
(30,054) |
|
Cash flows from financing activities |
|||
Payments of term loan debt |
(668,500) |
(28,558) |
|
Proceeds of term loan debt |
750,000 |
- |
|
(Repayments) borrowings on revolving credit facilities, net |
(10,418) |
39,143 |
|
Proceeds (repayments) on other debt, net |
2,131 |
(585) |
|
Financing-related debt issuance costs |
(3,734) |
- |
|
Dividends paid |
(22,302) |
(21,175) |
|
Stock options exercised, other |
(616) |
704 |
|
Net cash provided by (used in) financing activities |
46,561 |
(10,471) |
|
Effect of foreign exchange rate changes on cash |
(16,967) |
(2,486) |
|
Net decrease in cash, cash equivalents and restricted cash |
(26,285) |
(40,502) |
|
Cash, cash equivalents and restricted cash at the beginning of the period |
165,176 |
181,895 |
|
Cash, cash equivalents and restricted cash at the end of the period |
|
|
View original content to download multimedia:https://www.prnewswire.com/news-releases/quaker-houghton-announces-third-quarter-2022-results-301668356.html
SOURCE
Jeffrey Schnell, Senior Director, Investor Relations, investor@quakerhoughton.com, T. 1.610.832.4087